.svg?width=320){kind=logo}
Insilico Medicine's AI-developed drug rentosertib shows anti-aging effects in Phase III clinical trials
economy2 h ago
coda.news AI summary
- According to 极客公园, 42 participants with an average age of 67 were studied.
- According to 极客公园, after four weeks on rentosertib, about 3000 proteins were detected, with 326 showing significant changes.
- According to 极客公园, six models concluded the participants’ bodies appeared to be moving toward younger ages.
- According to 极客公园, clocks regressed by about 3–4 years on average, with one clock regressing by nearly 6 years.
极客公园Read original ↗
.svg?width=320){kind=logo}